Gordon W. Dewald
- Hematology top 0.05%
- Genetics top 0.05%
- Molecular Biology top 1%
- Pathology and Forensic Medicine top 0.2%
- Oncology top 1%
- Co-authors
- Martin S. TallmanElisabeth PaiettaAyalew TefferiJohn M. BennettRhett P. KetterlingRafaël FonsecaNeil E. KaySarah F. Paternoster
- Topics
- Acute Myeloid Leukemia Research (85 papers)Chronic Lymphocytic Leukemia Research (68 papers)Chronic Myeloid Leukemia Treatments (52 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Gordon W. Dewald
208 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 7.7k
- Genetics 5.2k
- Molecular Biology 4.4k
- Pathology and Forensic Medicine 2.6k
- Oncology 2.3k
Countries citing papers authored by Gordon W. Dewald
This map shows the geographic impact of Gordon W. Dewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon W. Dewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon W. Dewald more than expected).
Fields of papers citing papers by Gordon W. Dewald
This network shows the impact of papers produced by Gordon W. Dewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon W. Dewald. The network helps show where Gordon W. Dewald may publish in the future.
Co-authorship network of co-authors of Gordon W. Dewald
This figure shows the co-authorship network connecting the top 25 collaborators of Gordon W. Dewald. A scholar is included among the top collaborators of Gordon W. Dewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon W. Dewald. Gordon W. Dewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 256 | |
| 3 | 300 | |
| 4 | 96 | |
| 5 | 4 | |
| 6 | 34 | |
| 7 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletionbreakdown → | 893 |
| 8 | 8 | |
| 9 | 15 | |
| 10 | Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialbreakdown → | 502 |
| 11 | 54 | |
| 12 | 47 | |
| 13 | Clinical laboratory assays for HER-2/neu amplification and overexpression: Quality assurance, standardization, and proficiency testing | 65 |
| 14 | Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. | 139 |
| 15 | 11 | |
| 16 | 78 | |
| 17 | 31 | |
| 18 | 55 | |
| 19 | 9 | |
| 20 | 61 |
About Gordon W. Dewald
Gordon W. Dewald is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 212 papers that have together received 13.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (85 papers), Chronic Lymphocytic Leukemia Research (68 papers) and Chronic Myeloid Leukemia Treatments (52 papers). The work is most often cited by research in Hematology (7.7k citations), Genetics (5.2k citations) and Pathology and Forensic Medicine (2.6k citations). Gordon W. Dewald has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Martin S. Tallman, Elisabeth Paietta, Ayalew Tefferi, John M. Bennett, Rhett P. Ketterling, Rafaël Fonseca, Neil E. Kay, Sarah F. Paternoster, Philip R. Greipp and Mark R. Litzow. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.